Apomorphine C₁₇H₁₇NO₂
Active ingredient description
Apomorphine is a direct stimulant of dopamine receptors and while possessing both D1 and D2 receptor agonist properties does not share transport or metabolic pathways with levodopa. Its actions on parkinsonian motor disability are likely to be mediated at post-synaptic receptor sites.
Medicine classification
This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:
Product monographs
Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):
Structural formula
Chemical formula: C₁₇H₁₇NO₂
Molecular mass: 267.322 g/mol
3D molecular structure
External identifiers
Medicines
Apomorphine is an active ingredient of these brands:
Cyprus (CY)
- APO-GO as APOMORPHINE HYDROCHLORIDE
France (FR)
- APOKINON as APOMORPHINE HYDROCHLORIDE
- DOPACEPTIN as APOMORPHINE HYDROCHLORIDE
Japan (JP)
- APOKYN as APOMORPHINE HYDROCHLORIDE
Malta (MT)
- APO-GO as APOMORPHINE HYDROCHLORIDE
New Zealand (NZ)
- MOVAPO as APOMORPHINE HYDROCHLORIDE
Poland (PL)
- DACEPTON as APOMORPHINE HYDROCHLORIDE
South Africa (ZA)
- UPRIMA as APOMORPHINE HYDROCHLORIDE
Tunisia (TN)
- APOKINON as APOMORPHINE HYDROCHLORIDE
Turkey (TR)
While we strive to include the brand names of medicines across all countries, our index remains incomplete. Therefore, it is possible that this medicine may also be marketed under different names in other countries.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.